Brief: Redcare Pharmacy Outlook 2025 Total Sales To Grow In Excess Of 25%
11/03/2025 05:59
March 11 (Reuters) - REDCARE PHARMACY NV RDC.DE: FY ADJUSTED EBITDA MARGIN 1.4% (NOT 2.6)(CORRECTS NUMBER) FY NET INCOME EUR -46.4 MILLION FY ADJUSTED EBITDA EUR 33 MILLION FULL-YEAR GUIDANCE FOR 2025: TOTAL SALES TO GROW IN EXCESS OF 25% OUTLOOK 2025: RX IN GERMANY IN EXCESS OF EUR 0.5BN OUTLOOK 2025: TOTAL GROUP NON-RX SALES GROWTH IN EXCESS OF 18% OUTLOOK 2025: ADJUSTED. EBITDA MARGIN AT A POSITIVE 2% TO 2.5% FOR FULL YEAR Source text: [ID:] Further company coverage: RDC.DE (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))